stockrowCalumet, Inc.
CLMT Basic Materials Specialty Chemicals
Calumet, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.1 billion, down 1.25% from fiscal 2024.
- Revenue
- +40.8%
- EPS
- +35.9%
- Free cash flow
- +450.7%
- Total debt
- −1.98%
Quarter to June 2026, against a year earlier
Follow CLMT
Alert me
Calumet, Inc. (CLMT) Book value per share
Calumet, Inc.'s book value per share at the end of fiscal 2025 was −8.4×, compared with −8.6× in fiscal 2024. At the end of the quarter to 30 June 2026 it was −13.0×. Over the past ten years it has ranged from −8.6× (fiscal 2024) to 8.1× (fiscal 2015); the current reading is higher than 18% of that period. Calumet, Inc. ranks 61st of 61 Specialty Chemicals companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | −8.4× | — |
| FY2024 | −8.6× | — |
| FY2023 | −6.1× | — |
| FY2022 | −6.7× | — |
| FY2021 | −4.9× | — |
| FY2020 | −1.6× | — |
| FY2019 | 0.3× | (67.23%) |
| FY2018 | 0.8× | (45.45%) |
| FY2017 | 1.5× | (45.57%) |
| FY2016 | 2.8× | (64.80%) |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Jun 2026 | −13.0× | — |
| Mar 2026 | −12.0× | — |
| Dec 2025 | −8.4× | — |
| Sep 2025 | −8.0× | — |
| 42 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| FUL H. B. Fuller Company compare | 40.0× |
| CBT Cabot Corporation compare | 34.4× |
| SXT Sensient Technologies Corporation compare | 30.4× |
| HWKN Hawkins, Inc. compare | 27.2× |
| AVNT Avient Corporation compare | 26.9× |
| WDFC WD-40 Company compare | 20.3× |
| PRM Perimeter Solutions, SA compare | 8.1× |
| ASH Ashland Inc. compare | 0.0× |
| CLMT Calumet, Inc. | −13.0× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on CLMT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Beneish M-score
- The full statement